MEEDER ASSET MANAGEMENT INC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 149 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$87,000
-17.9%
2,628
+56.8%
0.01%0.0%
Q2 2021$106,000
-41.1%
1,676
-60.2%
0.01%
-44.4%
Q1 2021$180,000
+17.6%
4,207
-10.4%
0.01%
-10.0%
Q2 2020$153,000
+188.7%
4,693
+138.5%
0.01%
+150.0%
Q1 2020$53,000
-52.7%
1,968
-46.2%
0.00%
-42.9%
Q4 2019$112,000
+1500.0%
3,655
+1139.0%
0.01%
Q3 2019$7,000
-36.4%
295
-34.4%
0.00%
-100.0%
Q2 2019$11,000
+22.2%
4500.0%0.00%0.0%
Q1 2019$9,000
+80.0%
450
+2.5%
0.00%
Q4 2018$5,000
-99.8%
439
+230.1%
0.00%
Q2 2018$2,926,0001330.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
AJU IB Investment Co., Ltd. 1,114,962$63,776,00024.13%
Octagon Capital Advisors LP 548,374$31,367,00010.87%
Ghost Tree Capital, LLC 325,000$18,590,0004.14%
Burrage Capital Management LLC 81,357$4,654,0003.55%
Aufman Associates Inc 53,642$3,068,0002.75%
ACUTA CAPITAL PARTNERS, LLC 167,054$9,555,0002.60%
Cormorant Asset Management, LP 1,866,108$106,741,0002.54%
Tri Locum Partners LP 121,409$6,945,0002.52%
venBio Partners LLC 490,471$28,055,0002.48%
HHLR ADVISORS, LTD. 5,028,289$287,618,0002.29%
View complete list of APELLIS PHARMACEUTICALS INC shareholders